4DMedical Ltd.ASX: 4DX

Quarterly Activity Report and Appendix 4C for Q3 FY2025

· Issued by 4DMedical Ltd.

Filed with ASX · · 12 pages · English

Summary by 6ix AI

The report highlights a substantial increase in operating revenue year-to-date, alongside a successful cost reduction program that has already achieved notable savings. Additionally, the company is nearing completion of its regulatory submission for a key product, CT:VQ™, which has garnered interest from major medical institutions.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

4DMedical Ltd. on 6ix

Story so far

Earlier from 4DMedical

Later from 4DMedical

All 4DMedical news releases